Google’s sister company Verily, the former Google Life Sciences, is developing a wearable device that collects blood using tiny needles and magnets to make retrieval less invasive and less painful than current blood-testing procedures. Speculative use cases include tracking blood markers for people on clinical trials or taking samples from hospital patients without needing to wake them. Its current projects include next-generation surgical robots, novel techniques to control populations of disease-spreading mosquitoes, and new approaches to diabetes management. The new technology could also be used in other areas of medicine, such as detecting cancer cells by analyzing their DNA.
Google’s sister company Verily, the former Google Life Sciences, is developing a wearable device that collects blood using tiny needles and magnets to make retrieval less invasive and less painful than current blood-testing procedures. Speculative use cases include tracking blood markers for people on clinical trials or taking samples from hospital patients without needing to wake them. The new technology could also be used in other areas of medicine, such as detecting cancer cells by analyzing their DNA.